Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Hakushindo Pharmaceutical Co., Ltd." found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Hakushindo Pharmaceutical Co., Ltd. for you to read. Along with our medical data and news we also list Hakushindo Pharmaceutical Co., Ltd. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Hakushindo Pharmaceutical Co., Ltd. Companies for you to search.
Don aims to improve his times in four events, while able to do so because of new medications that keep his cancer in check eRace Cancer, a social media campaign to educate patients about advances and innovations in cancer treatments, said that Don Wright, now 78 years old, will be running in the Iowa Senior Games on Saturday, February 23, in Rock Islan...
Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that the company will participate at the 8th Annual SVB Leerink Healthcare Conference on Thursday, February 28, 2019 at the Lotte New York Palace, New York. About...
Will oversee the clinical development and regulatory submissions for company’s extensive pipeline, including two late-stage programs for the treatment of central nervous system disorders Cerevel Therapeutics, a biopharmaceutical company focused on developing new medicines to treat disorders of the central nervous system (CNS), today announced ...
- Proceeds to advance oral HIF-2α inhibitor, PT2977, into Phase 3 trial in advanced renal cell carcinoma – - Financing led by RA Capital Management - Peloton Therapeutics, Inc., a drug discovery and development company advancing first-in-class oral medicines for cancer and other serious conditions, today announced the closing of an oversubs...
Unique collaboration pairs HLT’s data technology and artificial intelligence with PPD’s global expertise in clinical trials and real-world evidence generation Pharmaceutical Product Development, LLC (PPD) and Happy Life Tech (
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced that Stefan Weber, CEO, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY on Wednesday, Februa...
The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Wednesday, February 27, 2019, at 8:30 a.m. EST to discuss its fourth-quarter and full-year 2018 financial results and operational developments. The conference call may be accessed by telephone as follows: ...
Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announces that Gaurav Shah, M.D., Chief Executive Officer and President of Rocket, will participate in a fireside chat at the 8th Annual SVB Leerink Global Healthcare Conference in New York City. The fireside chat will take pla...
Recursion, a clinical-stage biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover and develop drugs at scale, has been named to Fast Company’s annual list of the World’s Most Innovative Companies for 2019. The list honors the businesses making the most profound impact on both industry ...
A recent research study by Fact.MR finds that the microreactor sales reached approximately 294 thousand units in 2018 and are projected to grow at a Y-O-Y of nearly 9% in 2019. Increasing competition among manufacturers to develop efficient products remains a key aspect spurring the demand for microreactor technology. Enablement in facilitating effective and efficient drug synthesis is one of the ...
Darrin M Disley, PhD, DSc, OBE, appointed as CEO New investment from Ahren Innovation Capital, 24Haymarket and Dr Disley Mogrify’s technology enables the conversion of any mature cell type into any other mature cell type without going through a pluripotent stem cell- or progenitor cell-state ...
Austrian GENSPEED Biotech GmbH and Virogates A/S (Nasdaq First North Denmark: VIRO) have commenced a partnership to develop a rapid test for the risk classification of acute and chronic patients on site. The test targets to simultaneously analyze for C- Reactive Protein and suPAR from a finger prick in less than 10 minutes. Immediate results suppo...
Peter Leone Appointed Chief Business Officer Lee Kalowski, Chief Financial Officer, Promoted to U.S. President Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, today announced several key changes to its executive team, including t...
Entrectinib has been granted priority review for the treatment of neurotrophic tropomyosin receptor kinase (NTRK) fusion-positive, locally advanced or metastatic solid tumors in adult and paediatric patients. The The post Roche secures FDA priority review for entrectinib and polatuzumab vedotin appeared first on Pharmaceutical Business review.
The recommended dose of Keytruda for the adjuvant treatment of adult patients with melanoma is 200 mg administered as an intravenous infusion over 30 minutes every three weeks The post Merck gets FDA nod for Keytruda as adjuvant treatment for melanoma appeared first on Pharmaceutical Business review.
“Pfizer is dedicated to increasing access to biosimilars for patients suffering from serious illnesses and helping create a more sustainable healthcare system,” said Andreas Penk, M.D., regional president, The post Pfizer secures approval from European Commission for Avastin biosimilar appeared first on Pharmaceutical Business review.
The global MicroPump market will reach Volume Million USD in 2017 with CAGR xx% 20192023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report describes major products ...
ZOSYN IN PLASTIC CONTAINER (piperacillin sodium; tazobactam sodium) Wyeth pharms Patent: 6,207,661 Expiration: Feb 22, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical… The post Drug Patent Expirations for t... The post Drug Patent Expirations for the Week of February 17, 2019 appeared first on Biotechblog.
This chart shows the pharmaceutical companies with the most gum dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most gum dosed drugs… The post Which pharmaceutical companies have the most gum dosed dr... The post Which pharmaceutical companies have the most gum dosed drugs? appeared first on Biotechblog.
The University of Dundee Drug Discovery Unit has announced a partnership with Takeda, Japan's largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration, including Alzheimer's disease.
Pfizer has partnered with non-profit healthcare system Ochsner Health System to develop digital models that aim to improve clinical trials....Read More... The post Pfizer’s new partnership focuses on digitising clinical trials appeared first on Pharmaceutical Technology.
The US Food and Drug Administration (FDA) has accepted a new drug application (NDA) submitted by AbbVie for its investigational...Read More... The post FDA agrees to review AbbVie’s upadacitinib in rheumatoid arthritis appeared first on Pharmaceutical Technology.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a settlement with the Federal Trade Commission (FTC) that will resolve all outstanding litigation between the parties. Under the terms of the settlement, which is subject to court approval, the FTC will dismiss its claims against Teva and its affiliates in three outstanding cases, an...
ArticleAfter recently retired from a career at 3M spanning more than thirty years in drug delivery systems R&D, a scientist shares some thoughts and impressions on the industry.